A R Bianco

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

C. Focan, S. M. Steinberg, M Blichert-Toft et al. · PubMed · 1998 · 2.2K citations

Medicine, Oncology, Pharmacotherapy +5

Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.

Fortunato Ciardiello, Rosa Caputo, Roberto Bianco et al. · PubMed · 2001 · 646 citations

Medicine, Oncology, Pharmacology +17

Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer.

Giuseppe Di Lorenzo, Giampaolo Tortora, Francesco Paolo D’Armiento et al. · PubMed · 2002 · 475 citations

Medicine, Oncology, Urology +16

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases.

Chiara Carlomagno, Francesco Perrone, Ciro Gallo et al. · Journal of Clinical Oncology · 1996 · 409 citations

Medicine, Oncology, Breast Oncology +13

Antitumor Activity of ZD6474, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Human Cancer Cells with Acquired Resistance to Antiepidermal Growth Factor Receptor Therapy

Fortunato Ciardiello, Roberto Bianco, Roberta Caputo et al. · Clinical Cancer Research · 2004 · 347 citations

Medicine, Oncology, Pharmacology +17